P218   Click here for help

GtoPdb Ligand ID: 9740

Synonyms: MMV000147
PDB Ligand Antimalarial Ligand
Compound class: Synthetic organic
Comment: The antifolate compound P218 is a potent and selective inhibitor of P. falciparum bifunctional dihydrofolate reductase-thymidylate synthase (PfDHFR-TS) and was designed to overcome the emergence of parasite resistance to this class of antimalarial compound [7].

The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 10
Topological polar surface area 133.58
Molecular weight 360.18
XLogP 1.72
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCc1nc(N)nc(c1OCCCOc1ccccc1CCC(=O)O)N
Isomeric SMILES CCc1nc(N)nc(c1OCCCOc1ccccc1CCC(=O)O)N
InChI InChI=1S/C18H24N4O4/c1-2-13-16(17(19)22-18(20)21-13)26-11-5-10-25-14-7-4-3-6-12(14)8-9-15(23)24/h3-4,6-7H,2,5,8-11H2,1H3,(H,23,24)(H4,19,20,21,22)
InChI Key VDGXZSSDCDPCRF-UHFFFAOYSA-N
Bioactivity Comments
The interaction table below provides data from whole cell assays and gives the antiparasite activity of P218 against a number of Plasmodium lifecycle stages. The results include an evaluation of asexual blood stage activity, with high potency observed against both a wild-type and a clinically relevant pyrimethamine-resistant strain (PfV1/S) [7]. The compound is also active against hepatic schizonts [4] and has transmission blocking potential, inhibiting exflagellation in both wild-type PfNF54 (IC50 of 4 nM) and NF54-4mutPfdhfr, a transgenic strain with quadruple PfDHFR mutations (IC50 of 11 nM) [3].
Whole organism assay data
Key to terms and symbols Click on species/strain names for details Click column headers to sort
MOA/likely target Sp. Assay description Type Action Value Parameter Concentration range (M) Reference
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase Pf Parasite liver stage assay - - >7.9 pEC50 - 4
pEC50 >7.9 (EC50 <1.2x10-8 M) Primary human hepatocyte assay to assess inhibition of hepatic schizonts (prophylactic activity) [4]
Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite)
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase Pv Parasite liver stage assay - - 7.3 pEC50 - 4
pEC50 7.3 (EC50 4.5x10-8 M) Primary human hepatocyte assay to assess inhibition of hepatic schizonts (prophylactic activity) [4]
Lifecycle stages: Plasmodium liver stage (sporozoite, hepatic schizont, hepatic merozoite)
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase PfNF54 Parasite exflagellation assay - - 8.4 pIC50 - 3
pIC50 8.4 (IC50 4x10-9 M) Induction of male gamete activation (exflagellation) following 48 hour exposure of mature gametocytes to P218 [3]
Lifecycle stages: Plasmodium mosquito host stage (gametocyte, gamete, zygote, ookinete, oocyst, sporozoite)
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase PfTM4 Parasite growth inhibition assay - - 8.3 pIC50 - 7
pIC50 8.3 (IC50 4.6x10-9 M) [3H]-hypoxanthine incorporation [7]
Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase PfV1/S Parasite growth inhibition assay - - 7.3 pIC50 - 7
pIC50 7.3 (IC50 5.6x10-8 M) [3H]-hypoxanthine incorporation [7]
Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)